Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
06/1991
06/05/1991EP0429480A1 Natriuretic hormone
06/05/1991EP0429454A1 Improvements relating to the control of neoplastic tissue growth
06/05/1991EP0190292B1 Pharmaceutical preparation
06/05/1991CN1051936A Drythropoietin isoforms
06/05/1991CN1051934A Process for preparation of genelic vectors for nerve growth factor expression in eukaryotic cells
06/05/1991CN1051914A Peptides
06/05/1991CN1051912A Modified gangliosides and functional derivatives thereof
06/05/1991CN1051910A Benzoxazing derivatives and pharmaceutical compositions containing same
06/05/1991CN1051908A Process for direct isolation of captopril
06/05/1991CN1051907A 24-homo-vitamin-0-derivatives, process for preparing them, pharmaceutical preparation containing them and use as pharmaceuticals
06/05/1991CN1051905A Enzymatic resolution of endo bicyclo (2,2,1) heptan-2-01 and derived pharmaceutical agents
06/05/1991CN1051857A Preparartion method of water-soluable gel for lubricating vagina
06/05/1991CN1012733B Process for the preparation therapeutic agents and their use
06/05/1991CN1012732B Gen-dihalo-1, 8-diamino-4-aza-octanes
06/05/1991CA2070400A1 Heterocyclic substituted naphthyridinones and methods and compositions employing them
06/05/1991CA2070376A1 Glycyl-p-amino-pyridine for the treatment of senile dementia states
06/05/1991CA2046315A1 Bornyl and isobornyl esters of carboxylic acids of condensed tetrahydroquinoxalines
06/05/1991CA2031451A1 Imidazo¬1,2-a|pyridinylalkyl compounds for treatment of neurotoxic injury
06/05/1991CA2031446A1 Heterocyclic acyl aminodiol .beta.-amino acid derivatives
06/05/1991CA2031433A1 Use of nmda receptor antagonists
06/05/1991CA2031386A1 Extract from ginkgo biloba leaves, its method of preparation and pharmaceuticals containing the extract
06/05/1991CA2031376A1 Single layer transdermal drug administration system
06/05/1991CA2031320A1 Galactan sulfated derivative from klebsiella, a process for its preparation, its application as therapeutic agents and pharmaceuticals compositions containing the same
06/05/1991CA2029273A1 Modified nucleotide compounds
06/04/1991US5021597 Novel acrylic acid salts, a process for their preparation, pharmaceutical compositions containing them and their use in the medicine
06/04/1991US5021582 Famotidine polymorphic forms and their preparation process
06/04/1991US5021576 2-Anilino phenylacetic acid derivatives
06/04/1991US5021570 Aqueous solution containing fat-soluble vitamin K
06/04/1991US5021561 Complexes of iron or other metals with sulphonated derivatives of chitosan
06/04/1991US5021461 Method of treating diabetes mellitus with bisphenol derivatives
06/04/1991US5021458 Amine derivatives and fungicides containing the same
06/04/1991US5021457 Administering phenylpropanoamine
06/04/1991US5021456 Inhibitors of lysyl oxidase
06/04/1991US5021455 Solution for neutralizing caustic effects of alkaline cementitious materials on human skin
06/04/1991US5021452 Process for enhancing wound healing
06/04/1991US5021451 Method for inhibiting hyperproliferative diseases
06/04/1991US5021450 New class of compounds having a variable spectrum of activities for capsaicin-like responses, compositions and uses thereof
06/04/1991US5021449 N-pyrrolidinyl-3 alkyloxythienyl-2-carboxamides; antiemetics, antidepressants, schizophrenia
06/04/1991US5021448 Method of reducing serum uric acid and/or increasing renal uric acid clearance with thromboxane synthetase inhibitor inhibitor and/or thromboxane receptor antagonist
06/04/1991US5021445 Hyperglycemic and hypertensive agents; anticoagulants, alpha2-adrenoceptor antagonists
06/04/1991US5021444 Anticoagulants
06/04/1991US5021443 Noval benzimidazole and azabenzimiazole derivatives which are thromboxane receptor antagonists, their methods of preparation and pharmaceutical compositions in which they are present
06/04/1991US5021441 Organic compounds and their pharmaceutical use
06/04/1991US5021440 Imidazole compounds and their use as transglutaminase inhibitors
06/04/1991US5021438 1,3,4,5-tetrahydrobenz(c,d)indoles
06/04/1991US5021437 2-acetylpyridine 5-[(2-chloroanilino)thiocarbonyl]thiocarbonohydrazone compound and salts thereof
06/04/1991US5021435 Administering to a patient suffering from an ulcer caused by stress or gastric acid
06/04/1991US5021434 N-substituted imidazoles, as well as their use in pharmaceutical agents
06/04/1991US5021433 Novel pharmacological compounds
06/04/1991US5021432 Benzopyran compound and its pharmaceutical use
06/04/1991US5021430 Certain N-substituted butyramide derivatives
06/04/1991US5021429 Pharmacologically active aminoalkylphenyl compounds and their use
06/04/1991US5021426 Mixture with chloroquine, hydroxychloroquine, amodiaquine, mefloquine or salts thereof
06/04/1991US5021425 Use of 2-azabicycloi[2.2.2]octane-3-carboxylic acid derivatives for the treatment of arteritis
06/04/1991US5021424 Vitamin composition for treatment of flea infestation in animals
06/04/1991US5021423 Antibiotic, antitumor agent
06/04/1991US5021422 Administering to the skin of humans suffering from psoriasis
06/04/1991US5021420 Derivatives of (AZA)naphthalenesultam, their preparation and compositions containing them
06/04/1991US5021419 Novel pyrazinoxide compound of NF-1616-904 and a pharmaceutical composition containing the same
06/04/1991US5021418 Antihypertensive benzopyran compounds
06/04/1991US5021417 Use of a folinic acid substance as a platelet aggregation inhibitor
06/04/1991US5021416 Method for using (2-imidazolin-2-ylamino) quinoxalines to reduce or maintain intraocular pressure
06/04/1991US5021414 Phenol derivatives
06/04/1991US5021411 Imidazodiazepine derivatives
06/04/1991US5021410 Combinations of selective alpha-adrenergic agonists and antagonists useful in lowering intraocular pressure
06/04/1991US5021409 Antiviral cyclic polyamines
06/04/1991US5021408 Administering antiinflammatory agents
06/04/1991US5021407 Administering blocking agents which overcome antibiotic resistance
06/04/1991US5021406 2-pyranone derivative and process for production thereof
06/04/1991US5021405 Emollient durability enhancing siloxanes
06/04/1991US5021404 Administering proline hydroxylase inhibitors, collagen crosslinking inhibitors or trans-retinoic acid
06/04/1991US5021245 Treatment of colic; gastrointestinal disorder
06/04/1991US5021242 Solid drug preparations containing micronized crystals of ebselen
06/04/1991US5021241 Long-term sustained-release preparation
06/04/1991US5021234 Agent and product for the diagnosis and treatment of tumors and for the treatment of weaknesses of the cellular and humoral immune defense
06/04/1991CA1284654C ¬4.2.0|bicyclooctane derivatives with valuable therapeutic properties
06/04/1991CA1284651C Pharmaceutical compositions containing 5-phenyl-1, 3- dioxoalkenyl compounds
06/04/1991CA1284648C 7-oxabicyclo(2.2.1)heptane analogs
06/04/1991CA1284646C Cytoprotective derivatives useful in ischemic diseases, their preparation and compositions containing them
06/04/1991CA1284644C 7-oxabicycloheptane substituted keto-amide prostaglandin analogs
06/04/1991CA1284643C 7-oxabicycloheptane substituted diamide and its congener prostaglandin analogs
06/04/1991CA1284642C Prostacyclin (pgi ) analogues
06/04/1991CA1284640C Therapeutic compositions based on 3-alkoxyflavone derivatives, and novel 3-alkoxyflavone derivatives
06/04/1991CA1284636C 17.beta.-N-MONOSUBSTITUTED-CARBAMOYL-4-AZA-5.alpha.-ANDROSTAN-3-ONES
06/02/1991WO1991007976A1 Anti-thrombotic peptides and pseudopeptides
06/02/1991CA2069754A1 Anti-thrombotic peptides and pseudopeptides
06/02/1991CA2031324A1 Benzofuran derivatives
06/02/1991CA2031156A1 Anthelmintics
06/02/1991CA2031147A1 Anthelmintics
06/02/1991CA2028954A1 Process for preparing monohydrate 7-(d-2amino-2-phenylacetamido)-3-cefem-4-carboxylic acid and intermediate formed in the process
05/1991
05/31/1991WO1991008213A1 Oligoribonucloside and oligodeoxyribonucleoside boranophosphates
05/31/1991CA2069905A1 Oligoribonucleoside and oligodeoxyribonucleoside boranophosphates
05/31/1991CA2031078A1 Arylalkylazoles substituted by polyunsaturated radicals, processes for their preparation and their use
05/31/1991CA2031008A1 Cephalosporins
05/31/1991CA2030961A1 Angiotensin ii antagonists
05/31/1991CA2030737A1 Method for improving ventilation during sleep and treating sleep related ventilation abnormalities
05/31/1991CA2026354A1 Morphine hydrochloride preparation for rectal administration
05/31/1991CA2019986A1 Compositions and methods for increasing the growth rate of animals and improving the utilization of feed thereby
05/31/1991CA2019811A1 Substituted 3-aminosydnone imines, processes for their preparation and their use
05/30/1991WO1991008219A1 14-alpha,17-alpha-bridged 16-hydroxyestratrienes
1 ... 7345 7346 7347 7348 7349 7350 7351 7352 7353 7354 7355 7356 7357 7358 7359 7360 7361 7362 7363 7364 7365 ... 7860